Ventyx Biosciences Inc (VTYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 17,826 | 12,787 | 11,186 | 25,348 | 0 |
| Operating Income | -17,826 | -12,787 | -11,186 | -25,348 | N/A |
| Interest Expense | 0 | 0 | 0 | 99 | 0 |
| Other Income | 58 | 13 | -4,373 | -12,198 | 0 |
| Pre-tax Income | -17,768 | -12,774 | -15,559 | -37,645 | 0 |
| Net Income Continuous | -17,768 | -12,774 | -15,559 | -37,645 | N/A |
| Net Income | $-17,768 | $-12,774 | $-15,559 | $-37,645 | $N/A |
| EPS Basic Total Ops | 16.05 | -3.17 | -4.31 | -15.22 | N/A |
| EPS Basic Continuous Ops | 15.57 | -3.17 | -4.31 | -14.61 | N/A |
| EPS Diluted Total Ops | 16.05 | -3.17 | -4.31 | -15.22 | N/A |
| EPS Diluted Continuous Ops | 15.57 | -3.17 | -4.31 | -14.61 | N/A |
| EBITDA(a) | $-17,810 | $-12,778 | $-11,182 | $-25,347 | $N/A |